Allied Market Research
Loading...
Cart
0
PURCHASE OPTIONS

Start reading ,This title and over 12000 thousand more,available with Avenue Library, T&C*

Allied Market Research

Cell and gene supply chain services market - Global Opportunity Analysis and Industry Forecast, 2020-2027

A08188
Pages: NA
Jun 2021 | 209 Views
 
Author(s) : NA
Tables: NA
Charts: NA
 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Cell And Gene Supply Chain Services Market

Request Now !

Cells are the basic building blocks of all living organisms and genes are small sections of DNA, found within cells that carry genetic information. Cell and gene therapy represent overlapping fields of biomedical research with similar therapeutic goals, which target DNA or RNA in the body. Both of the approaches aim to modify genetic material present to improve its functioning or to immunize or fight against a certain disease and disorder. Precisely, gene therapy utilizes genetic material to engineer the patient’s cells for treatment of an inherited or acquired disease. On the other hand, cell therapy is transplantation of a set of whole new cells into the patient for the treatment of the disease. This therapy finds its application in the development of regenerative medicines. Headway is also being made for cell therapies derived from stem cells to maybe one day treat diseases like autoimmune diseases, Alzheimer’s, and Parkinson’s. The success of cell and gene therapies is not only credited to their capability of offering the desired therapeutic benefits, but also to effective utilization of all supply chain requirements which highlights the fact that supply chain holds significant share in growth and development of the cell and gene therapies and their distribution.

Cell-and-gene-supply-chain-services

Market scope and structure analysis:

Report Metric

Details

  Market size available for years

  2019–2027

  Base year considered

  2019

  Forecast period

  2020–2027

  Forecast units

  Value ($)

  Segments covered

  Technology, Application, End user and Region

  Region covered

•             North America (U.S., Canada, Mexico)

•             Europe (France, Germany, UK, Italy, Spain, Rest of Europe)

•             Asia-Pacific (Japan, China, India, Australia, South Korea, Rest          of Asia-Pacific)

•             LAMEA (Brazil, South Arabia, South Africa, Rest of LAMEA)

  Companies covered

BioTherapies, Brooks Life Sciences, Clarkston Consulting, Cryoport, Haemonetics, Hypertrust Patient Data Care, Lykan Bioscience, MAK-SYSTEM, MasterControl, SAP, SAVSU Technologies, sedApta Group, Stafa Cellular Therapy, Title21 Health Solutions, TraceLink, TrakCel, Vineti, etc.

 

COVID – 19 scenario analysis:  

  • Due to the ongoing COVID – 19 pandemic, lockdowns are in place restricting people to travel which has impacted the supply chain of these industries as well including biotech and pharmaceutical sector
  • Some of pharmaceutical companies in India have stated that they are stocked enough that inventory would last upto six months, but the impact on supply chains maybe truly felt if the lockdown extends beyond march
  • However, there have been supply interruptions in some European countries, China amidst the outbreak of Novel coronavirus
  • Global supply chains are set for a major overhaul as the COVID – 19 outbreak has exposed the vulnerability of countries and companies that rely on conventional supply chains
  • But, many of multi-national companies (MNCs) have started re-valuating, innovating their supply chains and are thinking about shuffling of their supply chains to reduce dependence on conventional methods

Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact Analysis

The entry of such treatment options with freedom to choose from has led to a paradigm shift in drug development, production and consumption. In addition, such therapies have actually enabled healthcare providers to treat several difficult-to-treat clinical conditions. The spending on healthcare sector has also increased with advancements in medical field leading to better diagnosis, treatment and increasing prevalence of diseases, both inherited and acquired. According to World Health Organization, the global healthcare expenditure is on a rise to be $8.5 trillion in 2020, owing to an increasing burden of chronic diseases, which are estimated to constitute almost 43% of the global economic burden. The ever increasing demand for better treatment, increased pool of patients with various diseases, favorable regulatory support and special designations for cell and gene therapy products and increasing funding for cell and gene therapy R&D activities is leading to an ascending need for preventive, precise healthcare and tailored medication.

Introduction of technologically advanced cell and gene therapies

Advanced therapy biomedical products, such as cell and gene therapies, have revolutionized healthcare sector and services. More than 30 such therapy products have been approved in the last two decades; recent approvals include Zolgensma, RECELL system, AmnioFix, EpiFix, EpiBurn, Alofisel, LUXTURNA, Yescarta and Kymriah. Further, according to a report by The Alliance for Regenerative Medicine in 2019, more than 1,000 clinical trials are being conducted globally by over 900 companies. In 2018, around $ 13 billion was invested in cell and gene therapies, representing 73% increase in capital investments, compared to the last year.  It is important to notice that, based on an analysis of the current pipeline of cell and gene therapies and the past clinical success of similar products, it is possible that around 10-20 advanced therapies would be approved by the US FDA each year, till 2025. The National Cancer Institute projects that nearly five million more U.S. citizens are expected to survive cancer in 2026 than in 2016. Henceforth, these developments in the therapies would mean an immense scope for supply chain.

Innovations in supply chains

The advanced therapy medicinal products supply chain is comparatively more complex than conventional pharmaceutical supply chain. Hence risks like operational inefficiencies, capacity scheduling concerns, process delays leading to capital losses and deliverable tracking-related issues. These concerns multiply in some situations, like the current ongoing COVID – 19 pandemic situation. This has created an urgency and a need for technological solutions, which can be integrated into existing processes to enable the engaged stakeholders to oversee and manage the various aspects of the cell and gene therapies supply chain, in compliance to global regulatory standards. 

Over the period of time, several advanced, innovative, software-enabled systems, offering supply chain orchestration and needle-to-needle traceability, have been developed. The market has also witnessed the establishment of numerous strategic partnerships between therapy developers and software solutions providers. Further, given the growing demand for cost-effective personalized medicinal products, and a myriad of other benefits of implementing such software solutions would see supply chain market grow significantly. For instance, TrakCel collaborating with supply chain services provider McKesson and WuXi to address supply chain challenges. In 2019, biotech major Lonza partnered with supply chain services provider Cryoport for logistics of cell and gene therapies globally.

Key segments:

Segments

Sub-segments

  Technology

  • Presence on cloud
  • Presence on-premises

  Applications

  • Ordering and scheduling
  • Sample collection
  • Logistics
  • Post treatment follow-up

  End User

  • Biobank/ cell-bank
  • Hospitals
  • Research institutes
  • Cell therapy labs
  • Others

 

Key benefits of the report:

  • This study presents the analytical depiction of the global cell and gene supply chain services industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global cell and gene supply chain services market share.
  • The current market is quantitatively analysed from 2020 to 2027 to highlight the global cell and gene supply chain services market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed global cell and gene supply chain services market analysis based on competitive intensity and how the competition will take shape in coming years.

Questions answered in the Cell and Gene Supply Chain Services Market research report:

  • Who are the leading market players active in the cell and gene supply chain services market?
  • What are the current trends that will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities in the cell and gene supply chain services market?
  • What are the projections for the future that will help in taking further strategic steps?
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.
 
PURCHASE OPTIONS

Start reading ,This title and over 12000 thousand more,available with Avenue Library, T&C*

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,   
Int'l : +1-503-894-6022
( Europe )
+ 44-845-528-1300
Drop us an email at
help@alliedmarketresearch.com

 
Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research

Access from any device, anywhere

Clients can easily download both quantitative as well as
qualitative reports in PDF and excel formats.

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

FREQUENTLY ASKED
QUESTIONS?

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 

REQUEST TOC/SAMPLE

OR

Purchase Full Report of
Cell and gene supply chain services market - Global Opportunity Analysis and Industry Forecast, 2020-2027- Global Opportunity Analysis and Industry Forecast, 2020-2027

  • Online Only
  • $3,456  $3,110
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $3,840  $3,456
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $5,769  $5,192
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,450  $5,805
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise
    License/PDF

  • $8,995  $8,096
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $ 699/mo
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Start reading.
    This title and over 12,000+ are available on the Avenue Library. T&C*.

    Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 

Featured Readings

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers